Standard InChI: InChI=1S/C18H24O4/c1-11(2)6-5-7-12(3)8-9-14-15(20)10-16(21)17(13(4)19)18(14)22/h6,8,10,20-22H,5,7,9H2,1-4H3/b12-8+
Standard InChI Key: RCOXTTLIGHDQHU-XYOKQWHBSA-N
Associated Targets(Human)
HeLa 62764 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A549 127892 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HT-29 80576 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HL-60 67320 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Arachidonate 5-lipoxygenase 6568 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cyclooxygenase-1 9233 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cyclooxygenase-2 13999 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Prostaglandin E synthase 3082 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Arachidonate 5-lipoxygenase 121 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Plasmodium falciparum 966862 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Mus musculus 284745 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 304.39
Molecular Weight (Monoisotopic): 304.1675
AlogP: 4.24
#Rotatable Bonds: 6
Polar Surface Area: 77.76
Molecular Species: NEUTRAL
HBA: 4
HBD: 3
#RO5 Violations: 0
HBA (Lipinski): 4
HBD (Lipinski): 3
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.80
CX Basic pKa:
CX LogP: 5.31
CX LogD: 5.16
Aromatic Rings: 1
Heavy Atoms: 22
QED Weighted: 0.54
Np Likeness Score: 2.25
References
1.Basabe P, de Román M, Marcos IS, Diez D, Blanco A, Bodero O, Mollinedo F, Sierra BG, Urones JG.. (2010) Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation., 45 (9):[PMID:20619940][10.1016/j.ejmech.2010.06.025]
2.Shaari K, Suppaiah V, Wai LK, Stanslas J, Tejo BA, Israf DA, Abas F, Ismail IS, Shuaib NH, Zareen S, Lajis NH.. (2011) Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase., 19 (21):[PMID:21958738][10.1016/j.bmc.2011.09.001]
3.Sun Q, Schmidt S, Tremmel M, Heilmann J, König B.. (2014) Synthesis of natural-like acylphloroglucinols with anti-proliferative, anti-oxidative and tube-formation inhibitory activity., 85 [PMID:25128665][10.1016/j.ejmech.2014.08.017]
4.Eaton AL, Dalal S, Cassera MB, Zhao S, Kingston DG.. (2016) Synthesis and Antimalarial Activity of Mallatojaponin C and Related Compounds., 79 (6):[PMID:27228055][10.1021/acs.jnatprod.6b00347]
5.Svouraki A, Garscha U, Kouloura E, Pace S, Pergola C, Krauth V, Rossi A, Sautebin L, Halabalaki M, Werz O, Gaboriaud-Kolar N, Skaltsounis AL.. (2017) Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones., 80 (3):[PMID:28240894][10.1021/acs.jnatprod.6b01008]